The Annual Psychopharmacology Summit at Sea:
Update on Psychopharmacology and Therapeutic Neuromodulation
CMECruisers is dedicated to offering continuing education courses on the latest innovations and research in the field of medicine and health care. Our presenters are experienced, well-published, and seasoned professionals who will help your CME experience be both informative and clinically relevant to your daily work.
CMECruisers Presenter
Philip G. Janicak, MD
Professor of Psychiatry, Rush University
Dr. Janicak is a Professor of Psychiatry at Rush University in Chicago, IL., and a Distinguished Fellow in the American Psychiatric Association. Dr. Janicak's primary research interests include the assessment and treatment of psychosis and mood disorders. He has been an NIMH grant awardee as both a principal and co-investigator.
An author and co-author of more than 200 publications in the psychiatric literature, Dr. Janicak is the first author of the book Principles and Practice of Psychopharmacotherapy, Lipincott-Williams & Wilkins, now in its fourth edition. He also enjoys speaking on topics related to his clinical research and has participated as a principal lecturer in over 500 courses, seminars, symposia and professional presentations.
Dr. Janicak completed his medical training and psychiatric residency at Loyola University of Chicago in 1976. He has been listed in the Best Doctors of America since 1996 and Who's Who in America since 2002. He was also named Psychiatrist of the Year by NAMI Illinois for 2003.
As a frequent and sought after presenter of pharmacology, Dr. Janicak looks forward to making this CME cruise experience informative, accessible, and unforgettable.
About Course
CME Summit Description and Objectives
The goal of this course is to review recent clinical trial results and use this information to develop optimal treatment strategies for the major psychiatric disorders.
Participants will: (1) recognize the significant number of patients who are insufficiently responsive to initial therapeutic interventions; (2) review biological treatments, including: the first- and second- generation antipsychotics, antidepressants, mood stabilizing agents, the anxiolytic/sedative hypnotics and device-based therapies; (3) learn to develop treatment strategies based on the results of randomized-controlled, pragmatic and naturalistic trials as tempered by the realities of clinical practice; and (4) review clinically relevant issues related to drug therapy, such as: Pharmacokinetics, pharmacodynamics, and Drug-Drug interactions
Session 1: CME Day 1-Morning: (3hrs. 15 min.)
SUPERBOWL SUNDAY!
Cont. breakfast & registration 9:00-9:20am
CME: 9:30-11:00 (1.5hrs.)
Break: 11-11:15
CME: 11:20-12:20 (1 hr.)
Closing: 12:20-12:30pm
- Introduction to psychopharmacotherapy
- Diagnosis and drug therapy of psychotic disorders
- Review CATIE-Schizophrenia, CUTLASS and CAFE trial results and their clinical relevance
LUNCH SERVED: 12:30-2:00pm
Session 2: CME Day 1 - Afternoon: (2hrs.)
CME: 2:30-3:30 (1 hr.)
Case Presentations: 3:30-4:30 (1 hr.)
Case breakout: 4:00-4:30
- Diagnosis and drug therapy of depressive disorders
- Review STAR*D and TADS trial results and their clinical relevance
- Case Study Presentations & Breakout
Session 3: Day 2 - Morning: (2hrs. 15 min)
Cont. breakfast & registration 9:00-9:20am
CME: 10:00-11:15 (1.5 hrs.)
Break: 11:15-11:30
CME: 11:30-12:00 (.5hrs.)
Closing: 12-12:15 pm
- (Previous Case Study Discussion & review)
- Device-based therapies in the management of mood disorders
- Review the role of electroconvulsive therapy (ECT), vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and deep brain stimulation (DBS)
- Case Study Presentation & Breakout
Session 4: Day 3 - Morning: (3hrs.)
Cont. breakfast & registration 9:00-9:20am
CME: 9:30-11:00 (1.5hrs)
Break: 11:00-11:15
CME: 11:20-12:50 (1.5hrs.)
Closing: 12:50-1 pm
- (Previous Case Study Discussion & review)
- Diagnosis and drug therapy of bipolar disorder
- Review STEP-BD trial results and its clinical relevance
- Diagnosis and drug therapy of dementia, including implications of CATIE-Alzheimer's trial results
- Case Study Presentation & Breakout
Session 5: Day 4 - Evening: (2hrs.)
Dinner Award Presentation
5:15 pm registration
CME: 5:30-6:30 (1 hr.)
Summary: 6:30-7:00 (30 min.)
Awards: 7:00-7:30 (30 min.)
- (Previous Case Study Discussion & review)
- Diagnosis and drug therapy of anxiety-related and sleep disorders
- Review problems regarding patient adherence to treatment, as well as strategies to improve compliance
- Summary and Conclusion
- Case Study Awards!
Curriculum schedule subject to change.
Any Questions? Email Us!
© 2007 The Hatherleigh Company, Ltd. - All rights reserved.